Dr. Jianrong Li’s novel study focuses on the brain’s support cells and myelin, exploring how genetic risk factors may trigger early changes linked to Alzheimer’s.

Texas A&M researchers are combining a common ingredient with high-level medical technology to find new treatments to long-term conditions.

The discovery promises breakthroughs in understanding the development of the motor neuron disease.

A new study, published in Nature, reveals a conserved genetic region that preserves species history through waves of gene flow and may be crucial to the development of some common X-linked diseases.

Texas A&M Health researcher explores how epigenetics link parents’ habits to long-term health outcomes in their children.

Researchers have created tools that respond to blue light with pinpoint accuracy, potentially revolutionizing cell therapy, cancer treatment and precision medicine.

Developed by biopharmaceutical company Ultragenyx, GTX-102 is the first clinically developed drug targeting the genetic causes of Angelman syndrome rather than symptoms.

Once consisting of two unique herds, researchers believe the Yellowstone bison herds should now be managed as one interbreeding population.

New research is shedding light on the genetic secrets of the Y chromosome in horses, revealing its role in lineage, breeding and conservation

The new system can also be used to assess and manage the genetic diversity of any species.